The Nanovaccine Institute is a consortium of researchers from public institutions and the private sector, coordinated by Iowa State University. Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and veterinary diseases.
Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.
Shared 1 year ago
475 views
Shared 1 year ago
397 views
Shared 2 years ago
77 views
Shared 2 years ago
7 views
Shared 2 years ago
301 views
Shared 2 years ago
63 views
Shared 2 years ago
330 views
Shared 2 years ago
33 views
Shared 2 years ago
31 views
Shared 2 years ago
54 views
Shared 3 years ago
184 views
